TCM Limited has announced the approval of its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors met on August 13, 2026, to consider and approve these results, along with the consolidated financial statements and limited review reports. The company also announced that its 82nd Annual General Meeting (AGM) will be held on September 25, 2026.
TCM Limited Announces Q1 FY27 Financial Results and Key Corporate Actions
TCM Limited has officially released its unaudited financial results for the first quarter of the fiscal year 2026-2027, ending on June 30, 2026. The company’s Board of Directors convened on Thursday, August 13, 2026, to review and approve these crucial financial statements, including both consolidated and standalone figures.
Key Financial Highlights
The Board approved the Consolidated and Standalone Unaudited Financial Results for the quarter ended June 30, 2026, accompanied by the respective Limited Review Reports. While the detailed figures are presented in the financial statements, the approval signifies the company’s performance during the period.
Annual General Meeting and Governance Updates
In addition to financial reporting, the Board also made significant decisions regarding corporate governance and future operations. The 82nd Annual General Meeting (AGM) of the Company has been scheduled for Friday, September 25, 2026. The Notice for the AGM has also been approved by the Board. Further, the Directors’ Report, Corporate Governance Report, and the Secretarial Audit Report for the Financial Year 2025-2026 have received their endorsement.
Shareholder and Director Matters
The company will proceed with the closure of its Share Transfer Register and Register of Shareholders in preparation for the AGM. A routine agenda item, the retirement of Directors by rotation, was also approved. Notably, the Board recommended the re-appointment of two Independent Directors, Mr. Gopalakrishnan Mahesh (DIN:0009278577) and Mr. Jose Jacob (DIN:0009280526), for a second term of five years. This proposed re-appointment will commence from September 29, 2026, and extend until September 28, 2031, subject to shareholder approval at the upcoming AGM.
Source: BSE